UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
42,833,193
Total 13F shares
43,924,518
Share change
-409,556
Total reported value
$12,621,620,981
Put/Call ratio
93%
Price per share
$287.35
Number of holders
662
Value change
-$132,393,705
Number of buys
350
Number of sells
288

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
13%
5,446,092
$1,678,866,729 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
10%
4,457,135
$1,374,001,007 31 Mar 2025
13F
Avoro Capital Advisors LLC
13F
Company
6.2%
2,675,000
$824,622,250 31 Mar 2025
13F
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.9%
from 13D/G
2,230,708
$687,660,355 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.9%
2,106,992
$649,522,424 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
4.7%
2,026,416
$624,683,261 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.9%
1,223,993
$377,240,583 31 Mar 2025
13F
FMR LLC
13F
Company
2.7%
1,144,603
$352,846,796 31 Mar 2025
13F
LSV ASSET MANAGEMENT
13F
Company
2.1%
902,323
$278,159,000 31 Mar 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
2.1%
908,448
$273,306,521 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.5%
624,711
$192,571,014 31 Mar 2025
13F
Pacer Advisors, Inc.
13F
Company
1.3%
548,092
$168,960,321 31 Mar 2025
13F
ASSETMARK, INC
13F
Company
1.2%
518,450
$159,822,582 31 Mar 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
1.1%
491,127
$151,399,764 31 Mar 2025
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
1.1%
477,757
$147,278,152 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.1%
471,365
$145,307,689 31 Mar 2025
13F
Invesco Ltd.
13F
Company
1.1%
465,115
$143,381,001 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.1%
454,983
$140,257,609 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.98%
420,795
$129,719,083 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.93%
400,207
$123,371,814 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.93%
398,230
$122,762,362 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.82%
350,858
$108,158,996 31 Mar 2025
13F
Amundi
13F
Individual
0.82%
350,193
$107,635,320 31 Mar 2025
13F
Swedbank AB
13F
Company
0.77%
330,513
$101,887,242 31 Mar 2025
13F
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
13F
Company
0.77%
328,783
$101,354,000 31 Mar 2025
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.73%
313,818
$96,740,530 31 Mar 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.7%
298,028
$91,873,165 31 Mar 2025
13F
Epoch Investment Partners, Inc.
13F
Company
0.67%
285,873
$88,126,070 31 Mar 2025
13F
AustralianSuper Pty Ltd
13F
Company
0.66%
282,739
$87,159,952 31 Mar 2025
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.64%
275,226
$84,843,919 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.63%
270,975
$83,533,463 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.6%
257,662
$79,429,465 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.58%
246,359
$75,945,089 31 Mar 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.57%
244,112
$75,252,264 31 Mar 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
0.57%
243,921
$75,194,000 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.56%
239,223
$73,745,273 31 Mar 2025
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.53%
226,287
$69,757,490 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.5%
212,996
$65,660,277 31 Mar 2025
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.48%
205,631
$63,390,000 31 Mar 2025
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.48%
205,241
$63,269,643 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.47%
200,686
$61,865,473 31 Mar 2025
13F
Pictet Asset Management Holding SA
13F
Company
0.47%
200,657
$61,820,943 31 Mar 2025
13F
Bridgewater Associates, LP
13F
Company
0.45%
193,784
$59,737,794 31 Mar 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.45%
191,389
$58,733,474 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.44%
190,370
$58,685,362 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.44%
189,731
$58,489,000 31 Mar 2025
13F
VIRGINIA RETIREMENT SYSTEMS ET Al
13F
Company
0.43%
186,200
$57,399,874 31 Mar 2025
13F
COMERICA BANK
13F
Company
0.43%
184,603
$56,907,498 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.43%
182,590
$56,287,019 31 Mar 2025
13F
HSBC HOLDINGS PLC
13F
Company
0.42%
179,706
$55,360,121 31 Mar 2025
13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2025

As of 30 Jun 2025, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 662 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,924,518 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., and LSV ASSET MANAGEMENT. This page lists 666 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
661
Q2 2025 holders
662
Holder diff
1
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.